Abstract
Weight loss, despite adequate caloric intake, occurs in Alzheimer's disease and cancer. Similar alterations of biochemistry accompany the weight loss in both diseases, and this suggests a common pathway of weight loss. If this hypothesis is correct, then drugs that prevent weight loss in cancer should also prevent weight loss in Alzheimer's disease. Megestrol acetate prevents weight loss in human and animal cancers. Omega 3 fatty acids prevent weight loss in animal models of cancer. Both compounds might prevent weight loss in Alzheimer patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
